1968 - Fellow of the American Association for the Advancement of Science (AAAS)
His primary areas of investigation include Immunology, Transplantation, Interleukin 21, Lymphokine-activated killer cell and Natural killer cell. His studies in Immunology integrate themes in fields like Stem cell and Cell therapy. His Transplantation research integrates issues from Gastroenterology and KIR Ligand.
His Interleukin 21 research is multidisciplinary, relying on both Interleukin 12 and Cell biology. The Lymphokine-activated killer cell study combines topics in areas such as CD16 and B cell. In his study, Cord Blood Stem Cell Transplantation is strongly linked to Umbilical cord, which falls under the umbrella field of Internal medicine.
His main research concerns Immunology, Transplantation, Internal medicine, Cancer research and Interleukin 21. His research in Immunology intersects with topics in Natural killer cell and Stem cell. His Transplantation study which covers Umbilical cord that intersects with Cord Blood Stem Cell Transplantation.
His Internal medicine research incorporates themes from Gastroenterology, Surgery and Oncology. His work in Cancer research addresses subjects such as Interleukin 15, which are connected to disciplines such as Adoptive cell transfer. The study incorporates disciplines such as Interleukin 12 and Cell biology in addition to Interleukin 21.
His primary areas of study are Cancer research, Immunology, Transplantation, Internal medicine and Immunotherapy. Jeffrey S. Miller interconnects Cell, Cell therapy, Cytokine, Antibody and Interleukin 15 in the investigation of issues within Cancer research. As part of his studies on Immunology, Jeffrey S. Miller often connects relevant areas like Cytotoxic T cell.
Jeffrey S. Miller has researched Transplantation in several fields, including Leukemia, Human leukocyte antigen and Myeloid leukemia. His Internal medicine study incorporates themes from Gastroenterology and Oncology. Jeffrey S. Miller has included themes like Natural killer cell, Adoptive cell transfer and Ovarian cancer in his Immunotherapy study.
Cancer research, Immunology, Immunotherapy, Immune system and Cell are his primary areas of study. His work deals with themes such as Cell culture, Natural killer cell, Cell therapy, CD16 and Chimeric antigen receptor, which intersect with Cancer research. His work carried out in the field of Immunology brings together such families of science as Cytotoxic T cell and Transplantation.
His Transplantation research is multidisciplinary, incorporating elements of Myeloid, Human leukocyte antigen, Epitope, Leukemia and Haplotype. His biological study spans a wide range of topics, including Interleukin, Cytokine, Interleukin 15 and Ovarian cancer. The various areas that Jeffrey S. Miller examines in his Immune system study include Hematopoietic stem cell transplantation, Myeloid-derived Suppressor Cell and Lymphoma.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.
Jeffrey S. Miller;Yvette Soignier;Angela Panoskaltsis-Mortari;Sarah A. McNearney.
Blood (2005)
Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy
Juliet N. Barker;Daniel J. Weisdorf;Todd E. DeFor;Bruce R. Blazar.
Blood (2005)
Tryptase Levels as an Indicator of Mast-Cell Activation in Systemic Anaphylaxis and Mastocytosis
Lawrence B. Schwartz;Dean D. Metcalfe;Jeffrey S. Miller;Harry Earl.
The New England Journal of Medicine (1987)
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.
Claudio G. Brunstein;Jeffrey S. Miller;Qing Cao;David H. McKenna.
Blood (2011)
Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia
Sarah Cooley;Daniel J. Weisdorf;Lisbeth A. Guethlein;John P. Klein.
Blood (2010)
Umbilical cord blood transplantation after nonmyeloablative conditioning: Impact on transplantation outcomes in 110 adults with hematologic disease
Claudio G. Brunstein;Juliet N. Barker;Daniel J. Weisdorf;Todd E. DeFor.
Blood (2007)
Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C natural killer cells with potent function
Bree Foley;Sarah Cooley;Michael R. Verneris;Michelle Pitt.
Blood (2012)
Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning.
Juliet N. Barker;Daniel J. Weisdorf;Todd E. DeFor;Bruce R. Blazar.
Blood (2003)
Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia
Sarah A Cooley;Elizabeth Trachtenberg;Tracy L. Bergemann;Koy Saeteurn.
Blood (2009)
Malignant neoplasms following bone marrow transplantation.
Smita Bhatia;Norma K.C. Ramsay;Michael Steinbuch;Kathryn E. Dusenbery.
Blood (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Minnesota
University of Minnesota
University of Colorado Denver
University of Minnesota
University of Minnesota
University of Minnesota
University of Minnesota
KU Leuven
University of Minnesota
University of California, San Diego
Technical University of Denmark
Korea Advanced Institute of Science and Technology
Imperial College London
Tel Aviv University
Natural Environment Research Council
National University of Río Cuarto
National Institute for Basic Biology
University of Oxford
Dartmouth College
University of Oxford
Chinese Academy of Sciences
Iowa State University
King's College London
Beth Israel Deaconess Medical Center
University of Nottingham
University of South Florida